Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure.
Hoa PQ, Kim HK, Jang TW, Seo H, Oh JY, Kim HC, Shin AY, Min J, Jayanti RP, Hung TM, Anh NK, Ahn S, Long NP, Cho YS, Shin JG; cPMTb.
Hoa PQ, et al. Among authors: hung tm.
Int J Antimicrob Agents. 2024 Feb;63(2):107034. doi: 10.1016/j.ijantimicag.2023.107034. Epub 2023 Nov 16.
Int J Antimicrob Agents. 2024.
PMID: 37977236
Free article.